News
Latest news from CHV and our portfolio companies
Featured News
January 20, 2026, Boston, MA: Catalyst Health Ventures (CHV), a venture capital firm focused on advancing transformative medical technologies, today announced the promotion of David Mackey to Partner. Mackey has…
Insights & Impacts: The latest from CHV
AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced
Esperto Medical™, Inc. a healthtech startup specializing in critical care and remote patient monitoring, announces
Sera Prognostics, Inc., The Pregnancy Company® (“Sera” or the “Company”) (Nasdaq: SERA), which focuses on
Epitel, Inc., a leader in AI technologies for patient-focused brain health solutions, is pleased to
Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150
Sera Prognostics, Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
Study will assess the Company’s Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial
Funding Will Support Clinical Studies of the VelocityTM pAVF System in Patients with Chronic Kidney
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health